Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Sees Large Increase in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 20,717 shares, an increase of 67.5% from the July 30th total of 12,368 shares. Based on an average daily volume of 4,199 shares, the days-to-cover ratio is presently 4.9 days.

Cardio Diagnostics Stock Performance

CDIOW traded down $0.01 during midday trading on Monday, reaching $0.01. The company’s stock had a trading volume of 23,196 shares, compared to its average volume of 42,170. The company has a fifty day simple moving average of $0.02 and a 200 day simple moving average of $0.02. Cardio Diagnostics has a twelve month low of $0.01 and a twelve month high of $0.07.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.